Richard A. Lewis MD

Richard A. Lewis, MD, is Director of the Neuromuscular Clinic and Professor of Neurology at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Lewis completed his neurology residency and electromyography fellowship at the University of Pennsylvania School of Medicine. He transitioned to the University of Connecticut, where he played a pivotal role in establishing the Neuromuscular Program, Electromyography Lab, and an Adult Muscular Dystrophy Clinic focusing on Amyotrophic Lateral Sclerosis (ALS). Dr. Lewis then assumed the role of Clinical Assistant Professor of Neurology at Norfolk’s Eastern Virginia Medical School, where he directed a Muscular Dystrophy Association clinic.

Dr. Lewis was Vice Chief of Neurology and Director of Clinical Neurophysiology at Harper University Hospital in Detroit, Michigan. At Wayne State University School of Medicine, he was Associate Clinical Chair of Neurology, directed the Hiller ALS Center, co-directed the Muscular Dystrophy Association Clinic at Detroit Medical Center, and led the Inflammatory Neuropathy Center of Excellence. He is the Past-President of the Peripheral Nerve Society and was the Chair of the Inflammatory Neuropathy Special Interest Group (SIG). He is a co-author of both the 2021 EAN/PNS CIDP Guidelines and the 2023 GBS Guidelines.

Dr. Lewis is widely acclaimed for his groundbreaking discovery and exploration of Lewis-Sumner syndrome, a variant of chronic inflammatory demyelinating polyneuropathy (CIDP), which is a chronic disorder that requires ongoing treatment to mitigate functional decline. His research endeavors and an extensive list of publications are focused on neuromuscular diseases, particularly those driven by neuroinflammation, such as CIDP and Guillain-Barré syndrome.